Percutaneous CT-Guided Renal Cryoablation: Technical Aspects, Safety, and Long-Term Oncological Outcomes in a Single Center
<i>Background and objectives:</i> Cryoablation is emerging as a safe and effective therapeutic option for treating renal cell carcinoma. This study analyzed the safety and long-term oncological outcomes of cryoablation in our center. <i>Materials and methods:</i> Patients who...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Medicina |
Subjects: | |
Online Access: | https://www.mdpi.com/1648-9144/57/3/291 |
id |
doaj-c662909d31f14aaab161b74e9a0a0b92 |
---|---|
record_format |
Article |
spelling |
doaj-c662909d31f14aaab161b74e9a0a0b922021-03-21T00:02:37ZengMDPI AGMedicina1010-660X1648-91442021-03-015729129110.3390/medicina57030291Percutaneous CT-Guided Renal Cryoablation: Technical Aspects, Safety, and Long-Term Oncological Outcomes in a Single CenterStefano Cernic0Cristina Marrocchio1Riccardo Ciabattoni2Ilaria Fiorese3Fulvio Stacul4Fabiola Giudici5Michele Rizzo6Maria Assunta Cova7Department of Radiology, ASUGI, Ospedale di Cattinara, 30149 Trieste, ItalyDepartment of Radiology, University of Trieste, ASUGI, Ospedale di Cattinara, 34149 Trieste, ItalyDepartment of Radiology, University of Trieste, ASUGI, Ospedale di Cattinara, 34149 Trieste, ItalyDepartment of Radiology, University of Trieste, ASUGI, Ospedale di Cattinara, 34149 Trieste, ItalyDepartment of Radiology, ASUGI, Ospedale Maggiore, 30125 Trieste, ItalyUnit of Biostatistics, Epidemiology and Public Health, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, 35122 Padova, ItalyDepartment of Urology, University, ASUGI, Ospedale di Cattinara, 30149 Trieste, ItalyDepartment of Radiology, University of Trieste, ASUGI, Ospedale di Cattinara, 34149 Trieste, Italy<i>Background and objectives:</i> Cryoablation is emerging as a safe and effective therapeutic option for treating renal cell carcinoma. This study analyzed the safety and long-term oncological outcomes of cryoablation in our center. <i>Materials and methods:</i> Patients who underwent computed tomography (CT)-guided percutaneous cryoablation between February 2011 and June 2020 for one or more clinically localized renal tumors were identified. Technical success and treatment efficacy were assessed. Post-procedural complications were classified according to the Clavien-Dindo system. Recurrence–free survival was determined for biopsy-proven malignant renal tumors. <i>Results:</i> A total of 174 renal tumors, 78 of which were biopsy-proven malignant carcinomas, were treated in 138 patients (97 males and 41 females, mean age: 73 years, range: 43–89 years). Mean tumor size was 2.25 cm and 54.6% of the lesions required a complex approach. Technical success was achieved in 171 out of 174 tumors (98.3%). Primary treatment efficacy was 95.3% and increased to 98.2% when retreats were taken into account. The overall complication rate was 29.8%. No complications of Clavien-Dindo grade III or more were encountered. Median follow-up was 21.92 months (range: 0.02–99.87). Recurrence-free survival was 100% at 1 year, 95.3% (95% CI: 82.1%–98.8%) at 3 years, and 88.6% (95% CI: 71.8%–95.7%) at 5 years. <i>Conclusions:</i> Cryoablation is a safe and effective technique for the treatment of small renal lesions, with no major complications when performed by expert interventional radiologists. The multidisciplinary discussion is essential, especially considering the high number of histologically undetermined lesions. Our long-term oncological outcomes are encouraging and in line with the literature.https://www.mdpi.com/1648-9144/57/3/291percutaneousrenal cryoablationinterventional radiologyrenal masstechnical aspectsoutcomes |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Stefano Cernic Cristina Marrocchio Riccardo Ciabattoni Ilaria Fiorese Fulvio Stacul Fabiola Giudici Michele Rizzo Maria Assunta Cova |
spellingShingle |
Stefano Cernic Cristina Marrocchio Riccardo Ciabattoni Ilaria Fiorese Fulvio Stacul Fabiola Giudici Michele Rizzo Maria Assunta Cova Percutaneous CT-Guided Renal Cryoablation: Technical Aspects, Safety, and Long-Term Oncological Outcomes in a Single Center Medicina percutaneous renal cryoablation interventional radiology renal mass technical aspects outcomes |
author_facet |
Stefano Cernic Cristina Marrocchio Riccardo Ciabattoni Ilaria Fiorese Fulvio Stacul Fabiola Giudici Michele Rizzo Maria Assunta Cova |
author_sort |
Stefano Cernic |
title |
Percutaneous CT-Guided Renal Cryoablation: Technical Aspects, Safety, and Long-Term Oncological Outcomes in a Single Center |
title_short |
Percutaneous CT-Guided Renal Cryoablation: Technical Aspects, Safety, and Long-Term Oncological Outcomes in a Single Center |
title_full |
Percutaneous CT-Guided Renal Cryoablation: Technical Aspects, Safety, and Long-Term Oncological Outcomes in a Single Center |
title_fullStr |
Percutaneous CT-Guided Renal Cryoablation: Technical Aspects, Safety, and Long-Term Oncological Outcomes in a Single Center |
title_full_unstemmed |
Percutaneous CT-Guided Renal Cryoablation: Technical Aspects, Safety, and Long-Term Oncological Outcomes in a Single Center |
title_sort |
percutaneous ct-guided renal cryoablation: technical aspects, safety, and long-term oncological outcomes in a single center |
publisher |
MDPI AG |
series |
Medicina |
issn |
1010-660X 1648-9144 |
publishDate |
2021-03-01 |
description |
<i>Background and objectives:</i> Cryoablation is emerging as a safe and effective therapeutic option for treating renal cell carcinoma. This study analyzed the safety and long-term oncological outcomes of cryoablation in our center. <i>Materials and methods:</i> Patients who underwent computed tomography (CT)-guided percutaneous cryoablation between February 2011 and June 2020 for one or more clinically localized renal tumors were identified. Technical success and treatment efficacy were assessed. Post-procedural complications were classified according to the Clavien-Dindo system. Recurrence–free survival was determined for biopsy-proven malignant renal tumors. <i>Results:</i> A total of 174 renal tumors, 78 of which were biopsy-proven malignant carcinomas, were treated in 138 patients (97 males and 41 females, mean age: 73 years, range: 43–89 years). Mean tumor size was 2.25 cm and 54.6% of the lesions required a complex approach. Technical success was achieved in 171 out of 174 tumors (98.3%). Primary treatment efficacy was 95.3% and increased to 98.2% when retreats were taken into account. The overall complication rate was 29.8%. No complications of Clavien-Dindo grade III or more were encountered. Median follow-up was 21.92 months (range: 0.02–99.87). Recurrence-free survival was 100% at 1 year, 95.3% (95% CI: 82.1%–98.8%) at 3 years, and 88.6% (95% CI: 71.8%–95.7%) at 5 years. <i>Conclusions:</i> Cryoablation is a safe and effective technique for the treatment of small renal lesions, with no major complications when performed by expert interventional radiologists. The multidisciplinary discussion is essential, especially considering the high number of histologically undetermined lesions. Our long-term oncological outcomes are encouraging and in line with the literature. |
topic |
percutaneous renal cryoablation interventional radiology renal mass technical aspects outcomes |
url |
https://www.mdpi.com/1648-9144/57/3/291 |
work_keys_str_mv |
AT stefanocernic percutaneousctguidedrenalcryoablationtechnicalaspectssafetyandlongtermoncologicaloutcomesinasinglecenter AT cristinamarrocchio percutaneousctguidedrenalcryoablationtechnicalaspectssafetyandlongtermoncologicaloutcomesinasinglecenter AT riccardociabattoni percutaneousctguidedrenalcryoablationtechnicalaspectssafetyandlongtermoncologicaloutcomesinasinglecenter AT ilariafiorese percutaneousctguidedrenalcryoablationtechnicalaspectssafetyandlongtermoncologicaloutcomesinasinglecenter AT fulviostacul percutaneousctguidedrenalcryoablationtechnicalaspectssafetyandlongtermoncologicaloutcomesinasinglecenter AT fabiolagiudici percutaneousctguidedrenalcryoablationtechnicalaspectssafetyandlongtermoncologicaloutcomesinasinglecenter AT michelerizzo percutaneousctguidedrenalcryoablationtechnicalaspectssafetyandlongtermoncologicaloutcomesinasinglecenter AT mariaassuntacova percutaneousctguidedrenalcryoablationtechnicalaspectssafetyandlongtermoncologicaloutcomesinasinglecenter |
_version_ |
1724211229987176448 |